4//SEC Filing
Ben Arye Barak 4
Accession 0001562180-24-001982
CIK 0001645113other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 4:30 PM ET
Size
14.5 KB
Accession
0001562180-24-001982
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Ben Arye Barak
General Counsel
Transactions
- Award
Ordinary Shares
2023-12-31$12.69/sh+128$1,624→ 35,323 total - Award
Ordinary Shares
2024-02-27$16.30/sh+81,799$1,333,324→ 117,122 total - Award
Stock Options (Right to buy)
2024-02-27$16.30/sh+125,078$2,038,771→ 125,078 totalExercise: $16.30From: 2025-02-27Exp: 2034-02-26→ Ordinary Shares (125,078 underlying)
Footnotes (4)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2023 through December 31, 2023. This transaction is also exempt under Rule 16b-3(c).
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2023.
- [F3]Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
- [F4]Options to buy 125,078 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001917165
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 4:30 PM ET
- Size
- 14.5 KB